In addition to the traditional challenges the life sciences sector has continually faced (stringent regulations unique to the field, long research periods, hefty expenses, and unknown, perhaps futile outcomes), the sector now faces headwinds other large-scale business activities must grapple with. These include mergers, acquisitions, restructuring, and digital overhauls. Despite the hurdles, many life sciences…